Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911073 · ClinicalTrials.gov registry record · NA
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health
A NA study of Obesity and Overweight, sponsored by ResBiotic Nutrition.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06911073: Recruiting NA study of Obesity and Overweight, sponsored by ResBiotic Nutrition.
NCT06911073 is a NA study of Obesity and Overweight that is actively recruiting participants, run by ResBiotic Nutrition. The registered enrollment target is 80 participants, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911073, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by ResBiotic Nutrition.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the impact of a specific oral postbiotic supplement on metabolic health in overweight adults.
Primary Outcome
Change from baseline in weight (lb)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Postbiotic
Study Locations (1)
Alabama
- Able Biolabs, LLC - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-05-02 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06911073 shows while recruiting
NCT06911073 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Obesity and Overweight appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06911073 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06911073 about?
NCT06911073 is a clinical study titled "A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health". This study aims to evaluate the impact of a specific oral postbiotic supplement on metabolic health in overweight adults.
What is the current status of trial NCT06911073?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-02. Estimated completion is 2025-12.
What conditions does trial NCT06911073 study?
This clinical trial studies the following conditions: Obesity and Overweight.
What interventions are being tested in trial NCT06911073?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Postbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06911073?
This trial is sponsored by ResBiotic Nutrition, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911073 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06911073's enrollment target sits among peer trials
80 12th of 27 higher than 16 of 27 other Obesity and Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity and Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
-
Weight Management Intervention in College: A Pilot
RECRUITING · NA
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
RECRUITING · NA
-
Muscle and Movement With Anti-Obesity Medications
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI